Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

November 1, 2014; Volume 55,Issue 11
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Edeline, Julien

    1. You have access
      High Prognostic Value of 18F-FDG PET for Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Long-Term Evaluation
      Haïfa Bahri, Lenoir Laurence, Julien Edeline, Houda Leghzali, Anne Devillers, Jean-Luc Raoul, Marc Cuggia, Habiba Mesbah, Bruno Clement, Eveline Boucher and Etienne Garin
      Journal of Nuclear Medicine November 1, 2014, 55 (11) 1786-1790; DOI: https://doi.org/10.2967/jnumed.114.144386
  2. Edelmann, Michelle

    1. You have access
      Regional Brain Glucose Metabolism and Neurocognitive Function in Adult Survivors of Childhood Cancer Treated with Cranial Radiation
      Kevin R. Krull, Satoshi Minoshima, Michelle Edelmann, Brannon Morris, Noah D. Sabin, Tara M. Brinkman, Gregory T. Armstrong, Leslie L. Robison, Melissa M. Hudson and Barry Shulkin
      Journal of Nuclear Medicine November 1, 2014, 55 (11) 1805-1810; DOI: https://doi.org/10.2967/jnumed.114.142950
  3. Elsinga, Philip H.

    1. You have access
      PET Imaging of Adenosine A1 Receptor Occupancy
      Soumen Paul, Shivashankar Khanapur, Philip H. Elsinga, Kiichi Ishiwata, Peter Meerlo, Rudi Dierckx and Aren van Waarde
      Journal of Nuclear Medicine November 1, 2014, 55 (11) 1918; DOI: https://doi.org/10.2967/jnumed.114.147736
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 55 (11)
Journal of Nuclear Medicine
Vol. 55, Issue 11
November 1, 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • PRRT: Defining the Paradigm Shift to Achieve Standardization and Individualization
  • Parametric Methods for Quantification of 18F-FAZA Kinetics in Non–Small Cell Lung Cancer Patients
  • The Detection of Sentinel Nodes in Ovarian Cancer: A Feasibility Study
  • Radionuclide Imaging in Ischemic Stroke
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire